| Code | Description | Claims | Beneficiaries | Total Paid |
| J9035 |
Injection, bevacizumab, 10 mg |
215 |
121 |
$960K |
| J9271 |
Injection, pembrolizumab, 1 mg |
16 |
13 |
$174K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
88 |
44 |
$107K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
24 |
14 |
$96K |
| J9070 |
Cyclophosphamide, 100 mg |
104 |
64 |
$74K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
602 |
317 |
$47K |
| J9190 |
Injection, fluorouracil, 500 mg |
790 |
361 |
$14K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
73 |
70 |
$9K |
| J9267 |
Injection, paclitaxel, 1 mg |
123 |
69 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,494 |
1,837 |
$6K |
| J3489 |
Injection, zoledronic acid, 1 mg |
75 |
62 |
$5K |
| J9045 |
Injection, carboplatin, 50 mg |
78 |
61 |
$3K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
70 |
38 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
289 |
229 |
$347.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
198 |
160 |
$220.68 |
| S0028 |
Injection, famotidine, 20 mg |
92 |
71 |
$34.80 |